
Ground-breaking data demonstrates tissue repair with Istesso’s novel investigational medicines
Istesso’s new class of developmental drugs, which inhibit mitochondrial complex...
17th July 2025Istesso’s new class of developmental drugs, which inhibit mitochondrial complex...
17th July 2025Istesso, the leading adaptive tissue-repair company, is pleased to announce...
4th June 2025Istesso Limited, the programmed disease resolution company, today announces that...
5th December 2022Istesso Limited, the programmed disease resolution company, today announces the...
6th September 2022Istesso Limited (“Istesso’’) was featured on Thisismoney.co.uk over the weekend,...
30th August 2022Istesso Limited (“Istesso’’) today announces headline results from the Phase...
15th July 2019Istesso Limited (“Istesso’’) today announces that it has completed a...
1st February 2019Istesso Limited (“Istesso’’) today announces that it has closed a...
12th December 2018Istesso Limited (‘’Istesso’’) is pleased to announce the appointment of...
20th September 2017